Robust detection of infectious disease, autoimmunity, and cancer from the paratope networks of adaptive immune receptors
Open Access
- 25 July 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (5)
Abstract
Liquid biopsies based on peripheral blood offer a minimally invasive alternative to solid tissue biopsies for the detection of diseases, primarily cancers. However, such tests currently consider only the serum component of blood, overlooking a potentially rich source of biomarkers: adaptive immune receptors (AIRs) expressed on circulating B and T cells. Machine learning–based classifiers trained on AIRs have been reported to accurately identify not only cancers but also autoimmune and infectious diseases as well. However, when using the conventional “clonotype cluster” representation of AIRs, individuals within a disease or healthy cohort exhibit vastly different features, limiting the generalizability of these classifiers. This study aimed to address the challenge of classifying specific diseases from circulating B or T cells by developing a novel representation of AIRs based on similarity networks constructed from their antigen-binding regions (paratopes). Features based on this novel representation, paratope cluster occupancies (PCOs), significantly improved disease classification performance for infectious disease, autoimmune disease, and cancer. Under identical methodological conditions, classifiers trained on PCOs achieved a mean AUC of 0.893 when applied to new individuals, outperforming clonotype cluster–based classifiers (AUC 0.714) and the best-performing published classifier (AUC 0.777). Surprisingly, for cancer patients, we observed that “healthy-biased” AIRs were predicted to target known cancer-associated antigens at dramatically higher rates than healthy AIRs as a whole (Z scores >75), suggesting an overlooked reservoir of cancer-targeting immune cells that could be identified by PCOs.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP20am0101108)
This publication has 46 references indexed in Scilit:
- Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapyCell, 2023
- Liquid biopsy enters the clinic — implementation issues and future challengesNature Reviews Clinical Oncology, 2021
- T cell repertoire sequencing as a cancer's liquid biopsy—can we decode what the immune system is coding?Current Opinion in Systems Biology, 2020
- Classification of intestinal T‐cell receptor repertoires using machine learning methods can identify patients with coeliac disease regardless of dietary gluten statusThe Journal of Pathology, 2020
- Large-scale network analysis reveals the sequence space architecture of antibody repertoiresNature Communications, 2019
- High frequency of shared clonotypes in human B cell receptor repertoiresNature, 2019
- The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A NephropathyJournal of Autoimmunity, 2019
- MMseqs2 enables sensitive protein sequence searching for the analysis of massive data setsNature Biotechnology, 2017
- Identifying specificity groups in the T cell receptor repertoireNature, 2017
- Quantifiable predictive features define epitope-specific T cell receptor repertoiresNature, 2017